27th January 2021, LifeTech Scientific Corporation obtained formal written notice from the National Medical Products Administration confirming the admission of Artery Stent Graft System into the NMPA Special Examination and Approval Procedure for Innovative Medical Services.
On 13 January 2021, G-iliac™ iliac artery bifurcation stent graft system, the novel device self-developed by LifeTech Scientific Corporation,has obtained the market registration approval from the China National Medical Products Administration.
On 24 December 2020, LAmbre™Left Atrial Appendage Closure System,developed by LifeTech Scientific Corporation,has obtained the approval by the US Food and Drug Administration for the commencement of an investigator-initiated clinical trial in the US.
IBS Titan™ iron alloy bioabsorbable peripheral stent system developed by Biotyx Medical, a holding subsidiary of LifeTech Scientific Corporation,was approved to enter the Special Examination and Approval Procedure for Innovative Medical Services by the National Medical Products Administration.
The 14th China Southern Endovascular Congress (SEC) was held in Nanchang successfully on 17th - 20th September 2020. Lifetech Scientific had a deep participation in the congress, and it successfully conducted series of academic exchange activities.
The 30th European Respiratory Society (ERS) Annual Meeting was successfully held online from 7th-9th September 2020.
IBS Angel™ iron alloy bioabsorbable stent system for blood vessels in lungs developed by Biotyx Medical, a holding subsidiary of LifeTech Scientific Corporation was approved to enter the Special Examination and Approval Procedure for Innovative Medical Services by the National Medical Products Administration.
On 19th-22th August 2020, the 2nd Annual Meeting of the Chinese Physicians Association Vascular Surgeons Branch was successfully held online. Lifetech Scientific had a deep participation in the meeting and successfully held two seminars.
The Left Atrial Appendage Closure (LAAC) Clinical Application Seminar Tour, which is initiated by China Atrial Fibrillation Center and organized by LifeTech Scientific, has been held in Liaoning province successfully.
The Left Atrial Appendage Closure (LAAC) Clinical Application Seminar Tour, initiated by China Atrial Fibrillation Center and organized by LifeTech Scientific, has been successfully held in Sichuan and Shanghai.